# Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis

> **NCT07437534** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Hayat Abad Medical Complex, Peshawar** · enrollment: 148 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Crisaborole 2% Topical Application Ointment [EUCRISA
- **DRUG:** tacrolimus 0.1%

## Key facts

- **NCT ID:** NCT07437534
- **Lead sponsor:** Hayat Abad Medical Complex, Peshawar
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2026-04-25
- **Final completion:** 2026-08-30
- **Target enrollment:** 148 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07437534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07437534, "Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07437534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*